Trade Mark Journal No.2026/009 27 February 2026
WO0000001898532 (9,35,41,44)
Office of origin: United States of America
Date of International Registration:4 November 2024
Date of designation in the UK:
4 November 2024
International priority date claimed: 3 May 2024
(United States of America)
(98533430)
International priority date claimed: 3 May 2024
(United States of America)
(98533442)
- Class 9
- Instructional and educational materials in the nature of electronic publications, namely, downloadable brochures concerning healthcare and medicine.
- Class 35
- Promoting public awareness of medical conditions, medical research, and options for diagnosis, treatment, and management; promoting public awareness by means of public advocacy of medical conditions, medical research, and options for diagnosis, treatment, and management.
- Class 41
- Educational services, namely, providing educational speakers, classes, workshops, conferences, and seminars in the fields of healthcare and medicine, and distribution of training materials in connection therewith; organisation of educational webinars in the fields of healthcare and medicine; production of instructional and educational materials, including newsletters and brochures concerning healthcare and medicine; providing non-downloadable electronic publications in the nature of non-downloadable electronic brochures concerning healthcare and medicine.
- Class 44
- Providing medical information; providing online information about medical services; providing information in the fields of healthcare, medicine, and cancer and oncological disorders via a website.
Jazz Pharmaceuticals Ireland Limited
Representative: Michael T. Olsen Winthrop & Weinstine, P.A., 225 South 6th Street, Suite 3500, Minneapolis MN 55402, UNITED STATES OF AMERICA